DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Earl HM, Cameron DA, Miles D et al.
PERSEPHONE: duration of trastuzumab with chemotherapy in women with HER2
positive early breast cancer.
Cancer Res 2012;
72 (Suppl. 24) 557s
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.